Home
All Journals
Expert Opinion on Investigational Drugs
List of Issues
Volume 21, Issue 8

Expert Opinion on Investigational Drugs

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Expert Opinion on Investigational Drugs, Volume 21, Issue 8 (2012)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Investigational Drugs, Volume 21, Issue 8 (2012)

See all volumes and issues

Vol 33, 2024 Vol 32, 2023 Vol 31, 2022 Vol 30, 2021 Vol 29, 2020 Vol 28, 2019 Vol 27, 2018 Vol 26, 2017 Vol 25, 2016 Vol 24, 2015 Vol 23, 2014 Vol 22, 2013 Volume 21, 2012 Vol 20, 2011 Vol 19, 2010 Vol 18, 2009 Vol 17, 2008 Vol 16, 2007 Vol 15, 2006 Vol 14, 2005 Vol 13, 2004 Vol 12, 2003 Vol 11, 2002 Vol 10, 2001 Vol 9, 2000 Vol 8, 1999 Vol 7, 1998 Vol 6, 1997 Vol 5, 1996 Vol 4, 1995 Vol 3, 1994

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Research Article

Article

Page: 1

Published online: 12 Jul 2012

46 Views
0 CrossRef citations
0Altmetric

Editorial

Polo-like kinases in AML

Tobias Berg, Gesine Bug, Oliver G Ottmann & Klaus Strebhardt

Pages: 1069-1074

Published online: 06 Jun 2012

AbstractforPolo-like kinases in AML | Full Text | References | PDF (297.4 KB)

1353 Views
9 CrossRef citations
0Altmetric

Free Access

Reviews

Review Article

Novel agents derived from the currently approved treatments for MM: novel proteasome inhibitors and novel IMIDs

Enrique M Ocio MD PhD, Maria-Victoria Mateos & Jesus F San-Miguel

Pages: 1075-1087

Published online: 24 May 2012

AbstractforNovel agents derived from the currently approved treatments for MM: novel proteasome inhibitors and novel IMIDs | Full Text | References | PDF (241 KB)

833 Views
17 CrossRef citations
0Altmetric

Review Article

Pharmacological management of hypertensive emergencies and urgencies: focus on newer agents

Pantelis A Sarafidis MD MSc PhD, Panagiotis I Georgianos MD, Pavlos Malindretos MD & Vassilios Liakopoulos MD PhD

Pages: 1089-1106

Published online: 06 Jun 2012

AbstractforPharmacological management of hypertensive emergencies and urgencies: focus on newer agents | Full Text | References | PDF (268.6 KB)

1701 Views
20 CrossRef citations
0Altmetric

Review Article

Tumor–stromal interactions in lung cancer: novel candidate targets for therapeutic intervention

Nefertiti El-Nikhely MSc, Leyre Larzabal MSc, Werner Seeger MD, Alfonso Calvo PhD & Rajkumar Savai PhD

Pages: 1107-1122

Published online: 06 Jun 2012

AbstractforTumor–stromal interactions in lung cancer: novel candidate targets for therapeutic intervention | Full Text | References | PDF (361.3 KB)

822 Views
26 CrossRef citations
0Altmetric

Review Article

Curcumin and neurodegenerative diseases: a perspective

Altaf S Darvesh MPharm PhD, Richard T Carroll PhD, Anupam Bishayee MPharm PhD, Nicholas A Novotny BS, Werner J Geldenhuys BPharm PhD & Cornelis J Van der Schyf DSc DTE

Pages: 1123-1140

Published online: 06 Jun 2012

AbstractforCurcumin and neurodegenerative diseases: a perspective | Full Text | References | PDF (288 KB)

1035 Views
127 CrossRef citations
0Altmetric

Review Article

Immunomodulatory agents in myelofibrosis

Ali Tabarroki & Ramon V Tiu MD

Pages: 1141-1154

Published online: 06 Jun 2012

AbstractforImmunomodulatory agents in myelofibrosis | Full Text | References | PDF (483.8 KB)

723 Views
13 CrossRef citations
0Altmetric

Review Article

Exploiting the anti-inflammatory effects of AMP-activated protein kinase activation

Ian P Salt & Timothy M Palmer

Pages: 1155-1167

Published online: 14 Jun 2012

AbstractforExploiting the anti-inflammatory effects of AMP-activated protein kinase activation | Full Text | References | PDF (391.8 KB)

976 Views
112 CrossRef citations
0Altmetric

Review Article

Drugs for bone healing

Maria Luisa Brandi MD PhD

Pages: 1169-1176

Published online: 14 Jun 2012

AbstractforDrugs for bone healing | Full Text | References | PDF (198.4 KB)

659 Views
25 CrossRef citations
0Altmetric

Drug Evaluations

Sorafenib in locally advanced or metastatic breast cancer

William J Gradishar MD

Pages: 1177-1191

Published online: 23 May 2012

Abstractfor Sorafenib in locally advanced or metastatic breast cancer | Full Text | References | PDF (349.7 KB)

500 Views
19 CrossRef citations
0Altmetric

TMC435 for the treatment of chronic hepatitis C

Sudeep Tanwar, Paul M Trembling & Geoffrey M Dusheiko

Pages: 1193-1209

Published online: 23 May 2012

Abstractfor TMC435 for the treatment of chronic hepatitis C | Full Text | References | PDF (333.3 KB)

535 Views
20 CrossRef citations
0Altmetric

Vandetanib for the treatment of lung cancer

Caleb T Chu, Yvonne H Sada & Edward S Kim MD

Pages: 1211-1221

Published online: 06 Jun 2012

Abstractfor Vandetanib for the treatment of lung cancer | Full Text | References | PDF (235.7 KB)

388 Views
5 CrossRef citations
0Altmetric

Vosaroxin: a novel antineoplastic quinolone

Jonathan A Abbas MD & Robert K Stuart MD

Pages: 1223-1233

Published online: 23 Jun 2012

Abstractfor Vosaroxin: a novel antineoplastic quinolone | Full Text | References | PDF (416.6 KB)

1154 Views
24 CrossRef citations
0Altmetric

Key Paper Evaluation

Article

More light at the end of the tunnel – apixaban in atrial fibrillation

Evaluation of Granger CB, Alexander JH, McMurray JJV et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2011, 365:981-92 and Connolly SJ Eikelboom J, Joyner C et al. Apixaban in patients with atrial fibrillation. N Engl J Med 2011, 364:806-17.

Sheila A Doggrell PhD DSc

Pages: 1235-1239

Published online: 13 Jun 2012

AbstractforMore light at the end of the tunnel – apixaban in atrial fibrillation | Full Text | References | PDF (182.7 KB)

263 Views
19 CrossRef citations
0Altmetric

Appendix

Correction

Erratum

Page: 1241

Published online: 06 Jul 2012

CitationforErratum | Full Text | PDF (84.4 KB)

272 Views
0 CrossRef citations
0Altmetric

Free Access

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Prospects of focal adhesion kinase inhibitors as a cancer therapy in preclinical and early phase study

Jiaming Gao et al.

Review Article | Published online: 27 Apr 2024

Investigational farnesoid X receptor agonists for the treatment of primary biliary cholangitis

Prithvi Reddy Akepati et al.

Review Article | Published online: 27 Apr 2024

Targeting diarrhea-predominant irritable bowel syndrome: hopes or hypes?

Gabrio Bassotti

Editorial | Published online: 25 Apr 2024

Free Access

Safety, tolerability, and pharmacokinetics of the novel RdRp inhibitor SHEN26 against SARS-CoV-2: a randomized, placebo-controlled, double-blind phase I study in healthy subjects

Cheng Sun et al.

Article | Published online: 25 Apr 2024

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Investigational Drugs (Vol.21, Iss.8, 2012)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?